Indian firm Cadila will complete trail of coronavirus vaccine by March
New Delhi: India's Zydus Cadila plans to complete late-stage trials for its novel coronavirus vaccine candidate by February or March and could produce up to 100 million doses a year initially if it is successful, the company…